Treatment Resistant Depression (TRD)

Neurology
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Soterix Medical
Soterix MedicalNJ - Woodbridge
2 programs
1
1
Accelerated rTMSPhase 21 trial
KetaminePhase 11 trial
Active Trials
NCT07307768Not Yet RecruitingEst. Mar 2028
NCT07287839Not Yet RecruitingEst. Jun 2028

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
Soterix MedicalAccelerated rTMS
Soterix MedicalKetamine

Clinical Trials (2)

NCT07287839Soterix MedicalAccelerated rTMS

Parcel-guided rTMS for Major Depressive Disorder

Start: Dec 2025Est. completion: Jun 2028
Phase 2Not Yet Recruiting
NCT07307768Soterix MedicalKetamine

Ketamine Biomarker Validation

Start: Dec 2025Est. completion: Mar 2028
Phase 1Not Yet Recruiting

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
8h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
8h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
9h ago

Director of Finance

CoMind
London, UK
9h ago

Electronics Engineering Manager

CoMind
London, UK
9h ago

Director of Information Technology

Zavation Medical Products
9h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Multiple Sclerosis(274)Schizophrenia(255)Epilepsy(242)Parkinson Disease(171)Alzheimer's Disease(165)Parkinson's Disease(160)Alzheimer Disease(117)Stroke(102)Relapsing-Remitting Multiple Sclerosis(83)Depression(82)